CN102660642A - Screening system for screening zinc finger protein - Google Patents
Screening system for screening zinc finger protein Download PDFInfo
- Publication number
- CN102660642A CN102660642A CN2012101228853A CN201210122885A CN102660642A CN 102660642 A CN102660642 A CN 102660642A CN 2012101228853 A CN2012101228853 A CN 2012101228853A CN 201210122885 A CN201210122885 A CN 201210122885A CN 102660642 A CN102660642 A CN 102660642A
- Authority
- CN
- China
- Prior art keywords
- zinc finger
- screening
- reporter
- preport
- egfp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012216 screening Methods 0.000 title claims abstract description 79
- 101710185494 Zinc finger protein Proteins 0.000 title claims abstract description 72
- 102100023597 Zinc finger protein 816 Human genes 0.000 title claims abstract description 72
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims abstract description 32
- 230000014509 gene expression Effects 0.000 claims abstract description 22
- 239000013598 vector Substances 0.000 claims description 98
- 239000013612 plasmid Substances 0.000 claims description 44
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 37
- 241000894006 Bacteria Species 0.000 claims description 27
- 230000004913 activation Effects 0.000 claims description 23
- 239000011701 zinc Substances 0.000 claims description 21
- 229910052725 zinc Inorganic materials 0.000 claims description 21
- 102100039556 Galectin-4 Human genes 0.000 claims description 20
- 108700008625 Reporter Genes Proteins 0.000 claims description 20
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 230000027455 binding Effects 0.000 claims description 17
- 101150011812 AADAC gene Proteins 0.000 claims description 16
- 238000003780 insertion Methods 0.000 claims description 16
- 230000037431 insertion Effects 0.000 claims description 16
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 claims description 15
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 230000003115 biocidal effect Effects 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 229940088710 antibiotic agent Drugs 0.000 claims description 7
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 6
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 23
- 230000002452 interceptive effect Effects 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 2
- 239000000969 carrier Substances 0.000 abstract 1
- 230000003321 amplification Effects 0.000 description 25
- 239000012634 fragment Substances 0.000 description 23
- 238000003199 nucleic acid amplification method Methods 0.000 description 19
- 238000012163 sequencing technique Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 239000002609 medium Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 230000009466 transformation Effects 0.000 description 10
- 238000013461 design Methods 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010076119 Caseins Proteins 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 108010001515 Galectin 4 Proteins 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 238000010363 gene targeting Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 3
- 101000741065 Bos taurus Beta-casein Proteins 0.000 description 3
- 101000845188 Homo sapiens Tetratricopeptide repeat protein 4 Proteins 0.000 description 3
- 229910021141 Sm—F Inorganic materials 0.000 description 3
- 102100031279 Tetratricopeptide repeat protein 4 Human genes 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102100022377 Homeobox protein DLX-2 Human genes 0.000 description 2
- 101000901635 Homo sapiens Homeobox protein DLX-2 Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- -1 TES Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- 238000001086 yeast two-hybrid system Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明属于锌指蛋白的筛选技术领域,涉及一种筛选锌指蛋白的筛选系统。The invention belongs to the technical field of screening zinc finger proteins, and relates to a screening system for screening zinc finger proteins.
背景技术 Background technique
转基因动物有着广泛的应用前景,通过基因打靶技术可以实现外源基因的定点整合,其表达可以实现精确调控并不影响宿主细菌自身基因表达调控。基因打靶主要依赖于同源重组,自然条件下同源重组发生的几率很低,约为百万之一,这就大大的限制了这一技术的广泛应用。如何提高基因打靶效率已经成为目前研究的重点和热点。Transgenic animals have broad application prospects. Gene targeting technology can achieve site-specific integration of exogenous genes, and its expression can be precisely regulated without affecting the regulation of host bacteria's own gene expression. Gene targeting mainly relies on homologous recombination. The probability of homologous recombination under natural conditions is very low, about one in a million, which greatly limits the wide application of this technology. How to improve the efficiency of gene targeting has become the focus and focus of current research.
锌指蛋白是一类具有手指状结构域的转录因子,在基因表达调控、细胞分化、胚胎发育、增强植物抗逆性等方面具有重要的作用。1996年Kim等发现,将已知的识别特异DNA序列的锌指结构与限制性内切酶FokI中无特异性识别作用的切割结构域通过一个“linker”融合表达,可以组合成一个新的限制性内切酶-锌指核酸酶(zinc finger nuclease,ZFN),识别和切割位点由其中的锌指结构决定。Zinc finger proteins are a class of transcription factors with finger-like domains, which play an important role in the regulation of gene expression, cell differentiation, embryonic development, and enhancement of plant stress resistance. In 1996, Kim et al. found that the known zinc finger structure for recognizing specific DNA sequences and the non-specific recognition cleavage domain of the restriction endonuclease FokI can be combined into a new restriction enzyme through a "linker" fusion expression. Sexual endonuclease-zinc finger nuclease (zinc finger nuclease, ZFN), the recognition and cutting site is determined by the zinc finger structure.
ZFN是由两部分组成,包括一个DNA结合域和一个非特异性核酸内切酶。其工作原理是DNA结合域与特定DNA结构结合,与之相连的非特异性核酸内切酶随之发挥剪切作用,在结合位点产生断裂,促进同源重组,提高定点突变和置换频率。研究表明,通过特异性锌指核酸酶可以提高基因打靶效率。锌指核酸酶的关键在于筛选高特异性、高亲和力的锌指蛋白。ZFNs are composed of two parts, including a DNA-binding domain and a nonspecific endonuclease. Its working principle is that the DNA-binding domain binds to a specific DNA structure, and the non-specific endonuclease connected to it then performs a cleavage effect, causing a break at the binding site, promoting homologous recombination, and increasing the frequency of site-directed mutation and replacement. Studies have shown that gene targeting efficiency can be improved by specific zinc finger nucleases. The key to zinc finger nucleases is to screen zinc finger proteins with high specificity and high affinity.
锌指蛋白的获取方法主要有筛选法和模块组装法。模块组装法的优点在于简易快速:简单将各锌指模块连接用于识别目标序列。缺点在于设计出的联体锌指亲和力较低或者没有亲和力。随着锌指结合DNA机制深入研究,该方法将会成为一种高效的方法;筛选法可信度较高,但比模块组装法耗时。The methods for obtaining zinc finger proteins mainly include screening method and module assembly method. The advantage of the module assembly method is that it is simple and fast: simply connect each zinc finger module to identify the target sequence. The disadvantage is that the designed conjoined zinc fingers have low or no affinity. With the in-depth study of the mechanism of zinc finger binding to DNA, this method will become an efficient method; the screening method has higher reliability, but it is more time-consuming than the module assembly method.
发明内容 Contents of the invention
本发明解决的问题在于提供一种筛选锌指蛋白的筛选系统,利用报告载体替代现有的细菌筛选系统必须将序列整合进细菌基因组里进行筛选的方法,筛选过程高效简洁。The problem to be solved by the present invention is to provide a screening system for screening zinc finger proteins, which uses a reporter carrier to replace the existing bacterial screening system that must integrate the sequence into the bacterial genome for screening, and the screening process is efficient and simple.
本发明是通过以下技术方案来实现:The present invention is achieved through the following technical solutions:
一种筛选锌指蛋白的筛选系统,包括两个报告载体pReport-N1-LacZ、pReport-N2-EGFP和一个激活载体pAD-RNAP-alpha-GAL4;A screening system for screening zinc finger proteins, comprising two reporter vectors pReport-N1-LacZ, pReport-N2-EGFP and one activation vector pAD-RNAP-alpha-GAL4;
所述的报告载体pReport-N1-LacZ包括锌指核酸酶识别序列插入位点、核糖体结合位点和启动子,在启动子的下游设有报告基因LacZ和抗生素筛选基因;The reporter vector pReport-N1-LacZ includes a zinc finger nuclease recognition sequence insertion site, a ribosome binding site and a promoter, and a reporter gene LacZ and an antibiotic screening gene are arranged downstream of the promoter;
所述的报告载体pReport-N2-EGFP包括锌指核酸酶识别序列插入位点、核糖体结合位点和启动子,在启动子的下游设有报告基因EGFP和抗生素筛选基因;The reporter vector pReport-N2-EGFP includes a zinc finger nuclease recognition sequence insertion site, a ribosome binding site and a promoter, and a reporter gene EGFP and an antibiotic screening gene are arranged downstream of the promoter;
所述的激活载体pAD-RNAP-alpha-GAL4包括RNA聚合酶α和激活元件GAL4。The activation vector pAD-RNAP-alpha-GAL4 includes RNA polymerase alpha and activation element GAL4.
所述的报告载体pReport-N1-LacZ的锌指核酸酶识别序列插入位点、核糖体结合位点和启动子的核苷酸序列如SEQ.ID.NO.1所示;The nucleotide sequence of the zinc finger nuclease recognition sequence insertion site, ribosome binding site and promoter of the reporter vector pReport-N1-LacZ is shown in SEQ.ID.NO.1;
所述的报告载体pReport-N2-EGFP的锌指核酸酶识别序列插入位点、核糖体结合位点和启动子的核苷酸序列如SEQ.ID.NO.2所示。The nucleotide sequence of the zinc finger nuclease recognition sequence insertion site, ribosome binding site and promoter of the reporter vector pReport-N2-EGFP is shown in SEQ.ID.NO.2.
所述的报告载体pReport-N1-LacZ和pReport-N2-EGFP上均设有单拷贝控制元件。Both the reporting vectors pReport-N1-LacZ and pReport-N2-EGFP are provided with single-copy control elements.
所述的报告载体pReport-N1-LacZ中的抗生素筛选基因为aada基因,报告基因LacZ和aada基因通过串联表达序列相连接;The antibiotic screening gene in the reporter vector pReport-N1-LacZ is the aada gene, and the reporter gene LacZ and the aada gene are connected through a tandem expression sequence;
所述的报告载体pReport-N2-EGFP中的抗生素筛选基因为aada基因,报告基因EGFP和aada基因通过串联表达序列相连接;The antibiotic screening gene in the reporter vector pReport-N2-EGFP is the aada gene, and the reporter gene EGFP and the aada gene are connected through a tandem expression sequence;
串联表达序列的核苷酸序列如SEQ.ID.NO.3所示。The nucleotide sequence of the tandem expression sequence is shown in SEQ.ID.NO.3.
所述的激活载体pAD-RNAP-alpha-GAL4中的RNA聚合酶α和激活元件GAL4通过表达五个氨基酸残基的linker序列连接。The RNA polymerase α in the activation vector pAD-RNAP-alpha-GAL4 is connected with the activation element GAL4 by expressing a linker sequence of five amino acid residues.
所述的五个氨基酸残基为Gly-Ser-Ala-Ala-Ala。The five amino acid residues are Gly-Ser-Ala-Ala-Ala.
所述的报告载体pReport-N1-LacZ、报告载体pReport-N2-EGFP中还通过锌指核酸酶识别序列插入位点插入锌指核酸酶识别序列。The reporting vector pReport-N1-LacZ and the reporting vector pReport-N2-EGFP also insert the zinc finger nuclease recognition sequence insertion site through the zinc finger nuclease recognition sequence insertion site.
所述的锌指蛋白识别序列为SEQ.ID.NO.4~SEQ.ID.NO.9所示的一种。The zinc finger protein recognition sequence is one shown in SEQ.ID.NO.4 to SEQ.ID.NO.9.
所述的报告载体pReport-N1-LacZ和激活载体pAD-RNAP-alpha-GAL4共转染于宿主细菌,构成LacZ报告系统;The reporter vector pReport-N1-LacZ and the activation vector pAD-RNAP-alpha-GAL4 are co-transfected into host bacteria to form a LacZ reporter system;
所述的报告载体pReport-N2-EGFP和激活载体pAD-RNAP-alpha-GAL4共转染于宿主细菌,构成EGFP报告系统。The reporter vector pReport-N2-EGFP and the activation vector pAD-RNAP-alpha-GAL4 are co-transfected into host bacteria to form an EGFP reporter system.
分别在LacZ报告系统和EGFP报告系统中转染待筛选的设有随机锌指蛋白和GAL11P元件的随机锌指库质粒;然后添加抗生素进行筛选阳性克隆,并根据报告基因的表达筛选出锌指蛋白质粒;再将LacZ报告系统筛选到的锌指蛋白质粒通过EGFP报告系统筛选,将EGFP报告系统筛选到的锌指蛋白质粒通过LacZ报告系统筛选。The random zinc finger library plasmids to be screened with random zinc finger proteins and GAL11P elements were transfected in the LacZ reporter system and the EGFP reporter system respectively; then antibiotics were added to screen positive clones, and the zinc finger proteins were screened out according to the expression of the reporter gene Then, the zinc finger protein particles screened by the LacZ reporter system were screened by the EGFP reporter system, and the zinc finger protein particles screened by the EGFP reporter system were screened by the LacZ reporter system.
与现有技术相比,本发明具有以下有益的技术效果:Compared with the prior art, the present invention has the following beneficial technical effects:
本发明提供的筛选锌指蛋白的筛选系统,是一种适用于从随机锌指质粒库中与锌指核酸酶识别序列相配合、识别的锌指蛋白,通过构建三种元件的配合,构建两套筛选系统,再通过这两套系统的交互筛选提高锌指蛋白筛选的活性。The screening system for screening zinc finger proteins provided by the present invention is a zinc finger protein suitable for matching and identifying zinc finger nuclease recognition sequences from a random zinc finger plasmid library. By constructing the cooperation of three elements, two A set of screening systems, and then through the interactive screening of these two systems to improve the activity of zinc finger protein screening.
巧妙利用三种元件的配合,从而实现锌指蛋白与锌指核酸酶识别序列特异性识别与报告基因表达指示的相关:The coordination of the three elements is cleverly used to realize the specific recognition of zinc finger protein and zinc finger nuclease recognition sequence and the correlation of reporter gene expression indication:
报告系统中的启动子包括插入位点和启动后续报告基因的启动子,在被激活的情况下启动后续的Laz报告基因和EGFP报告基因,实现不同的报告;The promoter in the reporter system includes the insertion site and the promoter that starts the follow-up reporter gene. When activated, the follow-up Laz reporter gene and EGFP reporter gene are started to realize different reports;
激活系统中的RNAP-alpha GAL4,其中GAL4为激活元件,RNAP为启动报告系统中的启动子;RNAP-alpha GAL4 in the activation system, wherein GAL4 is the activation element, and RNAP is the promoter in the start-up reporter system;
而待筛选的随机锌指库质粒中,锌指蛋白主要是与锌指核酸酶识别序列的结合,Gal11p也是激活元件;In the random zinc finger library plasmids to be screened, the zinc finger protein mainly binds to the zinc finger nuclease recognition sequence, and Gal11p is also an activation element;
当将设有的随机锌指库质粒转染到含有报告载体与激活载体都转染到宿主细菌中,如果位于报告载体的待筛选锌指蛋白结合位点能与随机锌指质粒中的某个锌指蛋白相互作用,则激活载体上GAL4与随机锌指库质粒上的与该锌指蛋白序列结合的GAL11P元件靠近并结合,GAL4与GAL11P结合后促使RNA聚合酶α结合在报告载体的启动子区从而激活报告基因LacZ或EGFP的表达;如果待筛选的识别位点与锌指蛋白无相互作用则不能激活报告基因表达。When the set random zinc finger library plasmid is transfected into the host bacteria containing both the reporter vector and the activation vector, if the binding site of the zinc finger protein to be screened in the reporter vector can be combined with one of the random zinc finger plasmids Zinc finger protein interaction activates GAL4 on the carrier to approach and bind to the GAL11P element that binds to the zinc finger protein sequence on the random zinc finger library plasmid, and the combination of GAL4 and GAL11P prompts RNA polymerase α to bind to the promoter of the reporter vector region to activate the expression of the reporter gene LacZ or EGFP; if the recognition site to be screened has no interaction with the zinc finger protein, the expression of the reporter gene cannot be activated.
而两套系统的相互验证是通过LacZ报告系统筛选得到的单克隆,提取质粒转入EGFP系统中鉴定EGFP活性;指通过EGFP报告系统筛选得到的单克隆,提取质粒转入LacZ系统中鉴定LacZ活性;通过两种系统的报告提高了筛选锌指蛋白的特异性。The mutual verification of the two systems is the single clone obtained through the screening of the LacZ reporter system, the extracted plasmid is transferred into the EGFP system to identify EGFP activity; refers to the single clone obtained through the screening of the EGFP reporter system, the extracted plasmid is transferred into the LacZ system to identify the LacZ activity ; Improved specificity for screening zinc finger proteins by reporting from both systems.
本发明提供的筛选锌指蛋白的筛选系统,筛选容量大,效率高,毒性小的特点:首先筛选系统利用报告载体的单拷贝性,替代过去细菌筛选系统必须将序列整合进细菌基因组里进行筛选的方法,筛选过程高效简洁,细菌生长快,转化效率高所以可以简单且快速的检测大量的相互作用;其次,应用细菌作为宿主避免了酵母等作为宿主,其宿主蛋白影响目的蛋白之间的相互作用;同时真核蛋白转入酵母会对宿主产生毒性,转入细菌就减少了细胞毒性的产生。The screening system for screening zinc finger proteins provided by the present invention has the characteristics of large screening capacity, high efficiency, and low toxicity: first, the screening system uses the single-copy nature of the reporter carrier, replacing the previous bacterial screening system that must integrate the sequence into the bacterial genome for screening The method, the screening process is efficient and concise, the bacteria grow quickly, and the transformation efficiency is high, so a large number of interactions can be detected simply and quickly; secondly, the use of bacteria as hosts avoids yeast as hosts, and its host proteins affect the interaction between target proteins Effect; at the same time, the transfer of eukaryotic proteins into yeast will cause toxicity to the host, and the transfer of eukaryotic proteins into bacteria will reduce the generation of cytotoxicity.
本发明提供的筛选锌指蛋白的筛选系统,以牛β酪蛋白基因上的锌指核酸酶识别位点为靶标,设计酪蛋白基因上的锌指核酸酶识别半位点,从随机锌指质粒库中筛选锌指蛋白,同时通过链霉素筛选与LacZ和链霉素与EGFP两个报告系统得到高特异性的锌指蛋白,并且筛选得到的锌指蛋白已经在牛成纤维细胞上进行了验证,其效果良好。The screening system for screening zinc finger proteins provided by the present invention takes the zinc finger nuclease recognition site on the bovine β casein gene as the target, designs the zinc finger nuclease recognition half site on the casein gene, and selects from a random zinc finger plasmid Zinc finger proteins were screened in the library, and highly specific zinc finger proteins were obtained through streptomycin screening and two reporter systems of LacZ and streptomycin and EGFP, and the zinc finger proteins obtained by screening have been tested on bovine fibroblasts Verified, it works fine.
附图说明 Description of drawings
图1为pRport-LacZ质粒图谱;Fig. 1 is pRport-LacZ plasmid map;
图2为HindIII与AvrII双酶切pMD19T-T-A与pRport-N1电泳图谱;Figure 2 is the electrophoresis pattern of pMD19T-T-A and pRport-N1 double digested with HindIII and AvrII;
图3为pRport-EGFP质粒图谱;Fig. 3 is pRport-EGFP plasmid map;
图4为HindIII和AvrII双酶切pReport-N2和PMD19T-T-E-A电泳图谱;Fig. 4 is HindIII and AvrII double digestion pReport-N2 and PMD19T-T-E-A electrophoresis pattern;
图5为pAD-R-G质粒图谱;Fig. 5 is pAD-R-G plasmid map;
图6为pAD-R-G酶切鉴定电泳图谱;Fig. 6 is pAD-R-G digestion and identification electrophoresis pattern;
图7为NheI与ASCI双酶切报告载体pReport-N1-T-L-A电泳图谱;Figure 7 is the electrophoresis pattern of the NheI and ASCI double-digested reporter vector pReport-N1-T-L-A;
图8为PCR鉴定插入牛酪蛋白半结合位点的报告载体pReport-N1-T-L-A-CN鉴定图谱;Figure 8 is a PCR identification map of the reporter vector pReport-N1-T-L-A-CN inserted into the half-binding site of bovine casein;
图9为Bsu36I酶切切报告载体pReport-N2-T-E-A电泳图谱;Fig. 9 is the electrophoresis pattern of the reporter vector pReport-N2-T-E-A digested with Bsu36I;
图10为PCR鉴定插入牛酪蛋白半结合位点的报告载体pReport-N2-T-E-A-CN鉴定图谱;Figure 10 is the PCR identification map of the reporter vector pReport-N2-T-E-A-CN inserted into the half-binding site of bovine casein;
图11-1~11-2为报告载体、激活载体与随机锌指质粒结合筛选系统的原理图;Figures 11-1 to 11-2 are schematic diagrams of the combination screening system of the reporter carrier, the activation carrier and the random zinc finger plasmid;
图12为PCR鉴定筛选得到的锌指蛋白。Figure 12 shows the zinc finger proteins identified and screened by PCR.
具体实施方式 Detailed ways
下面结合具体的实施例对本发明做进一步的详细说明,所述是对本发明的解释而不是限定。The present invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the present invention rather than limitations.
1、报告载体pReport-N1-LacZ的构建1. Construction of the reporter vector pReport-N1-LacZ
1.1设计重叠引物LWP1,LWP2,LWP3,LWP4,通过重叠PCR获得包含Asc I和Nhe I两个酶切位点(通过这两个酶切位点将锌指核酸酶识别序列插入)及-35、-10(弱启动子)、lac operator(乳糖启动子操纵子)和RBS(核糖体结合位点)基本元件的序列;所述的引物具体为:1.1 Design overlapping primers LWP1, LWP2, LWP3, LWP4, and obtain two restriction sites including Asc I and Nhe I through overlapping PCR (the zinc finger nuclease recognition sequence is inserted through these two restriction sites) and -35, -10 (weak promoter), lac operator (lactose promoter operon) and the sequence of RBS (ribosome binding site) basic element; Described primer is specifically:
LWP-1:gtacatgcat gctgtggaag ggcgcgcctg gctcgtaggc cgctagc;LWP-1: gtacatgcat gctgtggaag ggcgcgcctg gctcgtaggc cgctagc;
LWP-2:cggaagcata aagtgtaaag cccggggtgc ctaatgctag cggcctacg;LWP-2: cggaagcata aagtgtaaag cccggggtgc ctaatgctag cggcctacg;
LWP-3:ctttatgctt ccggctcgta tgttgtgtcg aattgtgagc ggataac;LWP-3: ctttatgctt ccggctcgta tgttgtgtcg aattgtgagc ggataac;
LWP-4:cggcctaggc ataagctttt cctgtgtgaa attgttatcc gctcac。LWP-4: cggcctaggc ataagctttt cctgtgtgaa attgttatcc gctcac.
第一轮分别扩增LWP12和LWP34片段;其扩增条件分别为:The first round amplifies the LWP12 and LWP34 fragments respectively; the amplification conditions are respectively:
LWP14ul;LWP24ul;pfu Mix(2x)25ul;ddH2O 17ul;LWP14ul; LWP24ul; pfu Mix (2x) 25ul; ddH 2 O 17ul;
LWP34ul;LWP2/LWP44ul;pfu Mix(2x)25ul;ddH2O 17ul;LWP34ul; LWP2/LWP44ul; pfu Mix (2x) 25ul; ddH 2 O 17ul;
扩增程序均为:95℃3min;95℃30s、50℃30s、72℃30s,10cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 50°C for 30s, 72°C for 30s, 10cycle; 72°C for 10min;
第二轮扩增LWP1234片段;其扩增条件为:The second round of amplification of the LWP1234 fragment; its amplification conditions are:
LWP1212.5ul;LWP3412.5ul;pfu Mix(2x)12.5ul;ddH2O 12.5ul;LWP1212.5ul; LWP3412.5ul; pfu Mix (2x) 12.5ul; ddH 2 O 12.5ul;
扩增程序均为:95℃3min;95℃30s、55℃30s、72℃30s,10cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 55°C for 30s, 72°C for 30s, 10cycle; 72°C for 10min;
第三轮扩增LWP片段;其扩增条件为:The third round of amplification of the LWP fragment; its amplification conditions are:
LWP12341ul;LWP15ul;LWP45ul;pfu Mix 12.5ul;ddH2O 12.5ul;LWP12341ul; LWP15ul; LWP45ul; pfu Mix 12.5ul; ddH 2 O 12.5ul;
扩增程序均为:95℃3min;95℃30s、60℃30s、72℃30s,30cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 60°C for 30s, 72°C for 30s, 30cycle; 72°C for 10min;
LWP片段PCR产物用2.5%琼脂糖电泳后,用胶回收试剂盒回收149bpDNA片段。After the LWP fragment PCR product was electrophoresed with 2.5% agarose, the 149 bp DNA fragment was recovered with a gel recovery kit.
将载体pReport和LWP片段分别用AvrII和SphI双酶切后,用T4连接酶连接(16℃水浴过夜连接)后得到载体pReport-N1。其中N1表示所构建的启动子,其核苷酸序列如SEQ.ID.NO.1所示,通过其实现锌指核酸酶识别序列的插入(Asc I和Nhe I两个酶切位点)以及lacz报告基因的启动。The vector pReport and LWP fragments were double-digested with AvrII and SphI, respectively, and ligated with T4 ligase (ligated overnight in a water bath at 16°C) to obtain the vector pReport-N1. Wherein N1 represents the promoter constructed, and its nucleotide sequence is as shown in SEQ.ID.NO.1, through which the insertion of the zinc finger nuclease recognition sequence (two restriction sites of Asc I and Nhe I) and Initiation of the lacz reporter gene.
将pReport-N1载体转化DH5α感受态细胞。将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,培养100ml菌液,用OMGA中提试剂盒提取质粒。The pReport-N1 vector was transformed into DH5α competent cells. Spread the transformation product evenly on a plate containing LB solid medium containing 100ug/ml amp, culture it upside down at 37°C for 12 hours, pick out a single colony, and select the correct single colony for sequencing after identification by colony PCR. Select a single colony with correct sequencing, culture 100ml of bacterial liquid, and extract the plasmid with the OMGA medium extraction kit.
1.2以载体pMD19T为基本骨架串联aada基因和lacz基因构建pMD19T-T-L-A载体1.2 Construct the pMD19T-T-L-A vector in series with the aada gene and lacz gene using the vector pMD19T as the basic backbone
1.2.1设计引物TES-1、TES-2通过重叠PCR扩增TES序列;TES-1、TES-2具体为:1.2.1 Design primers TES-1 and TES-2 to amplify the TES sequence by overlapping PCR; TES-1 and TES-2 are specifically:
TES-15′GCCGTCGACTAACCGGGCAGGCCATGTCTGCCCGTATTTCG 3′TES-15
TES-25′CGCGGATCCTTTCCTTACGCGAAATACGGGCAGACATGG 3′TES-25
TES序列的扩增体系为:pfu Mix 25ul;TES-15ul;TES-25ul;ddH2O15ul;The amplification system of TES sequence is: pfu Mix 25ul; TES-15ul; TES-25ul; ddH 2 O15ul;
扩增程序为:95℃3min;95℃30s、57℃30s、72℃15s,10cycle;72℃4min;最终得到的TES序列如SEQ.ID.NO.3所示;The amplification program is: 3min at 95°C; 30s at 95°C, 30s at 57°C, 15s at 72°C, 10cycle; 4min at 72°C; the final TES sequence is shown in SEQ.ID.NO.3;
回收扩增的TES序列后,分别用BamH I和Sal I双酶切载体PMD-19T和TES序列,用Solution I(Takara code D6022A)连接(16℃水浴过夜连接)后得到载体PMD19T-T;After the amplified TES sequence was recovered, the carrier PMD-19T and TES sequence were double-digested with BamH I and Sal I respectively, and connected with Solution I (Takara code D6022A) (connected overnight in a water bath at 16°C) to obtain the carrier PMD19T-T;
将PMD19T-T载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,培养100ml菌液,用OMGA中提试剂盒提取质粒。The PMD19T-T vector was transformed into DH5α competent cells, and the transformation product was evenly spread on a plate containing 100ug/ml amp LB solid medium, and after being inverted at 37°C for 12 hours, single colonies were picked and identified by colony PCR. Select the correct single colony for sequencing. Select a single colony with correct sequencing, culture 100ml of bacterial liquid, and extract the plasmid with the OMGA medium extraction kit.
1.2.2设计引物Sm-F、Sm-R,以载体pCDFDuet-1为模板扩增aada片段,Sm-F、Sm-R具体为:1.2.2 Design primers Sm-F and Sm-R to amplify the aada fragment using the vector pCDFDuet-1 as a template. Sm-F and Sm-R are specifically:
Sm-F:ggggatccat gagggaagcg gtgat;Sm-F: ggggatccat gagggaagcg gtgat;
Sm-R:gctgaattcc taggtcaggc atttgagaag c;Sm-R: gctgaattcc taggtcaggc atttgagaag c;
扩增程序为:95℃3min;95℃45s、53℃30s、72℃90s,30cycle;72℃4min;The amplification program is: 95°C for 3min; 95°C for 45s, 53°C for 30s, 72°C for 90s, 30cycle; 72°C for 4min;
回收扩增的aada片段后,分别用EcoR I和BamH I双切载体pMD19T-T和aada片段,以在TES片段下游插入链霉素表达基因(aada),用Solution I连接(Takara code D6022A)(16℃水浴过夜连接)后得到载体PMD19T-T-A;After recovering the amplified aada fragment, EcoR I and BamH I were used to double-cut the vector pMD19T-T and aada fragment respectively to insert the streptomycin expression gene (aada) downstream of the TES fragment, and connect with Solution I (Takara code D6022A) ( 16°C water bath overnight connection) to obtain the carrier PMD19T-T-A;
将PMD19T-T-A载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The PMD19T-T-A vector was transformed into DH5α competent cells, and the transformation product was uniformly spread on a plate containing LB solid medium containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and a single colony was picked, and after identification by colony PCR, Select the correct single colony for sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
1.2.3设计引物对LacZ-F、LacZ-R,以载体pLenti6/V5-GW/lacZ为模板扩增LacZ基因,LacZ-F、LacZ-R具体为:1.2.3 Design the primer pair LacZ-F and LacZ-R, and use the vector pLenti6/V5-GW/lacZ as a template to amplify the LacZ gene. LacZ-F and LacZ-R are specifically:
LacZ-F:gggcagcga agcttatgat agatcccgtc g;LacZ-F: gggcagcga agcttatgat agatcccgtc g;
LacZ-R:cgcggtcgac ttattatttt tgacaccaga cca;LacZ-R: cgcggtcgac ttaattatttt tgacaccaga cca;
扩增程序为:95℃3min;95℃45s、60℃30s、72℃5min,30cycle;72℃10min;The amplification program is: 95°C for 3min; 95°C for 45s, 60°C for 30s, 72°C for 5min, 30cycle; 72°C for 10min;
回收扩增的LacZ,分别用Sal I和Sph I双切载体pMD19T-T-A和LacZ,以在TES序列上游插入LacZ基因的读码框,用Solution I(Takara codeD6022A)连接(16℃水浴过夜连接)后得到载体PMD19T-T-L-A;Recover the amplified LacZ, use Sal I and Sph I double-cutting vectors pMD19T-T-A and LacZ, respectively, to insert the reading frame of the LacZ gene upstream of the TES sequence, and connect with Solution I (Takara codeD6022A) (16°C water bath for overnight connection) Finally, the vector PMD19T-T-L-A was obtained;
将PMD19T-T-L-A载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The PMD19T-T-L-A vector was transformed into DH5α competent cells, and the transformation product was uniformly spread on a plate containing LB solid medium containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and single colonies were picked out, and after identification by colony PCR, Select the correct single colony for sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
1.2.3通过HindIII和AvrII双酶切pReport-N1和pMD19T-T-L-A载体,回收相应片段,连接两片段用Solution I(Takara code D6022A)连接(16℃水浴过夜连接)得到基本报告载体pReport-N1-LacZ(pReport-N1-T-L-A)。其质粒图谱如图1所示,可以看到上述构建的元件的排列如下:N1启动子(RBS、Asc I/Nhe I酶切位点及-35、-10、lac operator、)lacZ、TES、Aada。1.2.3 Digest the pReport-N1 and pMD19T-T-L-A vectors with HindIII and AvrII, recover the corresponding fragments, connect the two fragments with Solution I (Takara code D6022A) (16°C water bath overnight connection) to obtain the basic reporter vector pReport-N1- LacZ (pReport-N1-T-L-A). Its plasmid map is shown in Figure 1. It can be seen that the elements constructed above are arranged as follows: N1 promoter (RBS, Asc I/Nhe I restriction site and -35, -10, lac operator,) lacZ, TES, Aada.
所构建的pReport-N1和pMD19T-T-L-A双酶切图谱如图2所示,其中M为Trans15K。泳道1为pMD19T-T-L-A载体质粒;泳道2,3为HindIII与AvrII双酶切pMD19T-T-L-A载体结果,大小为4071bp;泳道4,5为HindIII与AvrII双酶切pReport-N1结果,大小为12309bp;泳道6为pReport-N1质粒条带.The constructed double restriction map of pReport-N1 and pMD19T-T-L-A is shown in Figure 2, where M is Trans15K.
将pReport-LacZ载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The pReport-LacZ vector was transformed into DH5α competent cells, and the transformation product was uniformly spread on a plate containing LB solid medium containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and single colonies were picked, and identified by colony PCR, Select the correct single colony for sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
2、载体pReport-N2-EGFP的构建2. Construction of vector pReport-N2-EGFP
2.1设计重叠引物EWP-1、EWP-2、EWP-3、EWP-4,通过重叠PCR获得连续两个Bsu36I酶切位点及-35、-10、lac operator和RBS基本元件的序列,所述的引物具体为:2.1 Design overlapping primers EWP-1, EWP-2, EWP-3, EWP-4, obtain the sequence of two consecutive Bsu36I restriction sites and -35, -10, lac operator and RBS basic elements by overlapping PCR, described The primers are specifically:
EWP-1:gccatcgatt gtggaagggc gcgcctggct cgtaggccgc atgc;EWP-1: gccatcgatt gtggaagggc gcgcctggct cgtaggccgc atgc;
EWP-2:cggaagcata aagtgtaaag cccggggtgc ctaatcctaa ggggcctac;EWP-2: cggaagcata aagtgtaaag cccggggtgc ctaatcctaa ggggcctac;
EWP-3:ctttatgctt ccggctcgta tgttgtgtcg aattgtgagc ggataac;EWP-3: ctttatgctt ccggctcgta tgttgtgtcg aattgtgagc ggataac;
EWP-4:cggcctaggc ataagctttt cctgtgtgaa attgttatcc gctcac;EWP-4: cggcctaggc ataagctttt cctgtgtgaa attgttatcc gctcac;
第一轮分别扩增EWP12和EWP34片段;其扩增条件分别为:In the first round, EWP12 and EWP34 fragments were amplified respectively; the amplification conditions were as follows:
EWP14ul;EWP24ul;pfu Mix(2x)25ul;ddH2O 17ul;EWP14ul; EWP24ul; pfu Mix (2x) 25ul; ddH 2 O 17ul;
EWP34ul;EWP2/LWP44ul;pfu Mix(2x)25ul;ddH2O 17ul;EWP34ul; EWP2/LWP44ul; pfu Mix (2x) 25ul; ddH 2 O 17ul;
扩增程序均为:95℃3min;95℃30s、50℃30s、72℃30s,10cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 50°C for 30s, 72°C for 30s, 10cycle; 72°C for 10min;
第二轮扩增EWP1234片段;其扩增条件为:The second round of amplification of the EWP1234 fragment; its amplification conditions are:
EWP1212.5ul;EWP3412.5ul;pfu Mix(2x)12.5ul;ddH2O 12.5ul;EWP1212.5ul; EWP3412.5ul; pfu Mix (2x) 12.5ul; ddH 2 O 12.5ul;
扩增程序均为:95℃3min;95℃30s、55℃30s、72℃30s,10cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 55°C for 30s, 72°C for 30s, 10cycle; 72°C for 10min;
第三轮扩增EWP片段;其扩增条件为:The third round of amplification of the EWP fragment; its amplification conditions are:
EWP12341ul;LWP15ul;LWP45ul;pfu Mix 12.5ul;ddH2O 12.5ul;EWP12341ul; LWP15ul; LWP45ul; pfu Mix 12.5ul; ddH 2 O 12.5ul;
扩增程序均为:95℃3min;95℃30s、60℃30s、72℃30s,30cycle;72℃10min;The amplification programs are: 95°C for 3min; 95°C for 30s, 60°C for 30s, 72°C for 30s, 30cycle; 72°C for 10min;
EWP片段PCR产物用2.5%琼脂糖电泳后,用胶回收试剂盒回收146bpDNA片段。After the EWP fragment PCR product was electrophoresed with 2.5% agarose, the 146bp DNA fragment was recovered with a gel recovery kit.
将载体pReport和EWP片段分别用AvrII和Sph I双酶切后,用T4连接酶连接(16℃水浴过夜连接)后得到载体pReport-N2。其中N2表示所构建的启动子,其核苷酸序列如SEQ.ID.NO.2所示,通过其实现锌指核酸酶识别序列的插入(两个Bsu36I酶切位位点)以及EGFP报告基因的启动。The vector pReport and EWP fragments were double-digested with AvrII and Sph I, respectively, and ligated with T4 ligase (overnight ligation in a water bath at 16°C) to obtain the vector pReport-N2. Wherein N2 represents the promoter constructed, and its nucleotide sequence is shown in SEQ.ID.NO.2, through which the insertion of the zinc finger nuclease recognition sequence (two Bsu36I restriction sites) and the EGFP reporter gene are realized start.
将pReport-N2载体转化DH5α感受态细胞。将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,培养100ml菌液,用OMGA中提试剂盒提取质粒。The pReport-N2 vector was transformed into DH5α competent cells. Spread the transformation product evenly on a plate containing LB solid medium containing 100ug/ml amp, culture it upside down at 37°C for 12 hours, pick out a single colony, and select the correct single colony for sequencing after identification by colony PCR. Select a single colony with correct sequencing, culture 100ml of bacterial liquid, and extract the plasmid with the OMGA medium extraction kit.
2.2以载体pMD19T为基本骨架串联aada基因和EGFP基因构建pMD 19T-T-E-A载体2.2 Construct the pMD 19T-T-E-A vector in series with the aada gene and EGFP gene using the vector pMD19T as the basic backbone
2.2.1设计引物对EGFP-F、EGFP-R,以载体pEGFP-C1为模板扩增EGFP基因,EGFP-F、EGFP-R具体为:2.2.1 Design the primer pair EGFP-F and EGFP-R, and use the carrier pEGFP-C1 as a template to amplify the EGFP gene. EGFP-F and EGFP-R are specifically:
EGFP-F:gctgcatgcg aagcttagg tgagcaaggg;EGFP-F: gctgcatgcg aagcttagg tgagcaaggg;
EGFP-R:ggagtcgact tattacttgt acagctcgtc catgcc;EGFP-R: ggagtcgact tattacttgt acagctcgtc catgcc;
扩增程序为:95℃3min;95℃45s、60℃30s、72℃90s,30cycle;72℃10min;The amplification program is: 95°C for 3min; 95°C for 45s, 60°C for 30s, 72°C for 90s, 30cycle; 72°C for 10min;
回收扩增的EGFP,分别用Sal I和Sph I双切载体pMD19T-T-A和EGFP,用Solution I连接(16℃水浴过夜连接),从而TES序列上游插入EGFP,得到载体PMD19T-T-E-A;Recover the amplified EGFP, use Sal I and Sph I double-cut vectors pMD19T-T-A and EGFP respectively, and connect with Solution I (16°C water bath for overnight connection), so that the upstream of the TES sequence is inserted into EGFP to obtain the vector PMD19T-T-E-A;
将PMD19T-T-E-A载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The PMD19T-T-E-A vector was transformed into DH5α competent cells, and the transformation product was uniformly spread on a plate containing LB solid medium containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and a single colony was picked, and after identification by colony PCR, Select the correct single colony for sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
2.2.2通过HindIII和Avr II双酶切pReport-N2和PMD19T-T-E-A载体,回收相应片段,连接两片段用Solution I连接(16℃水浴过夜连接)得到基本报告载体pReport-N2-EGFP(pReport-N2-T-E-A)。其质粒图谱如图2所示,可以看到上述构建的元件的排列如下:N2启动子(RBS、两个Bsu36I酶切位点及-35、-10、lac operator、)EGFP、TES(串联表达序列)、Aada。2.2.2 Digest the pReport-N2 and PMD19T-T-E-A vectors with HindIII and AvrII, recover the corresponding fragments, and connect the two fragments with Solution I (16°C water bath overnight connection) to obtain the basic reporter vector pReport-N2-EGFP (pReport- N2-T-E-A). Its plasmid map is shown in Figure 2, and it can be seen that the elements constructed above are arranged as follows: N2 promoter (RBS, two Bsu36I restriction sites and -35, -10, lac operator,) EGFP, TES (tandem expression sequence), Aada.
双酶切pReport-N2和PMD19T-T-E-A载体图谱如图4所示:其中M为frans15k;泳道1为pReport-N2被HindIII和AvrII双切,其双切后的大小为12461bp;泳道2为PMD19T-T-E-A被HindIII和AvrII双切,其双切后的大小1731bp。The double-digested pReport-N2 and PMD19T-T-E-A vector maps are shown in Figure 4: where M is frans15k;
将pReport-EGFP载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定后,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The pReport-EGFP vector was transformed into DH5α competent cells, and the transformation product was uniformly spread on the LB solid medium plate containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and a single colony was picked, and after identification by colony PCR, Select the correct single colony for sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
3、激活载体pAD-RNAP-alpha GAL4(pAD-R-G)的构建3. Construction of activation vector pAD-RNAP-alpha GAL4 (pAD-R-G)
3.1以载体pBD-LGF2为模板扩增Gal4片段,扩增引物为:3.1 Use the carrier pBD-LGF2 as a template to amplify the Gal4 fragment, and the amplification primers are:
Gal4-F:ggcgcggccg cagaatcaa;Gal4-F: ggcgcggccg cagaatcaa;
Gal4-R:ctcgaactag ttcaaaataa tcctgttaac aat;Gal4-R: ctcgaactag ttcaaaataa tcctgttaac aat;
扩增程序为:95℃3min;95℃30s、57℃45s、72℃45s,35cycle;72℃10min;The amplification program is: 95°C for 3min; 95°C for 30s, 57°C for 45s, 72°C for 45s, 35cycle; 72°C for 10min;
回收扩增的Gal4,分别用Not I和Spe I双切载体pTRG和Gal4,T4DNA连接酶16℃过夜连接后,得到载体pTRG-R-G;The amplified Gal4 was recovered, and Not I and Spe I were used to double-cut the vectors pTRG and Gal4, respectively, and T4 DNA ligase was ligated overnight at 16°C to obtain the vector pTRG-R-G;
将pTRG-R-G载体转化DH5α感受态细胞,将转化产物均匀涂布在含有100ug/ml amp的LB固体培养基的平板中,37℃倒置培养12h后,挑去单菌落,通过菌落PCR鉴定,选取正确单菌落测序。选取测序正确单菌落,摇菌,提试剂盒提取质粒。The pTRG-R-G vector was transformed into DH5α competent cells, and the transformation product was evenly spread on the plate containing LB solid medium containing 100ug/ml amp, and cultured upside down at 37°C for 12 hours, and single colonies were picked, identified by colony PCR, and selected Correct single colony sequencing. Select a single colony with correct sequencing, shake the bacteria, and extract the plasmid with the extraction kit.
3.2以pTRG-R-G载体为模板扩增RNAP-alpha GAL4,扩增引物为:3.2 Use the pTRG-R-G vector as a template to amplify RNAP-alpha GAL4, and the amplification primers are:
28R-F:ctcgaattca aataagtgcc ttcccatca;28R-F: ctcgaattca aataagtgcc ttcccatca;
28R-R:gcgagatctc gctcagtgga acgaaaa;28R-R: gcgagatctc gctcagtgga acgaaaa;
扩增程序为:95℃3min;95℃45s、60℃45s、72℃90s,30cycle;72℃10min;The amplification program is: 95°C for 3min; 95°C for 45s, 60°C for 45s, 72°C for 90s, 30cycle; 72°C for 10min;
回收扩增的RNAP-alpha GAL4,分别用BglII与NcoI双切载体pAD及RNAP-alpha GAL4,T4DNA连接酶16℃过夜连接后,得到载体pAD-R-G;其质粒图谱如图5所示,可以看到目标元件RNAP-alpha GAL4克隆到相应的位置。其酶切鉴定结果如图6所示:M1为Trans 2k plus DNA Marker;M2Trans 15k DNA Marker;1、2为pAD-R-G激活载体的两个不同单克隆酶切结果,两个片段大小分别为5582bp和885bp。Recover the amplified RNAP-alpha GAL4, use BglII and NcoI to double-cut the vector pAD and RNAP-alpha GAL4, and T4 DNA ligase to ligate overnight at 16°C to obtain the vector pAD-R-G; its plasmid map is shown in Figure 5, you can see To the target element RNAP-alpha GAL4 cloned into the corresponding position. The results of enzyme digestion identification are shown in Figure 6: M1 is Trans 2k plus DNA Marker; M2Trans 15k DNA Marker; 1 and 2 are the results of two different monoclonal digestions of the pAD-R-G activation vector, and the size of the two fragments is 5582bp and 885bp.
4、为了验证上述两个报告载体,具体的以牛β酪蛋白基因上的锌指核酸酶识别位点为靶标,设计以下酪蛋白基因上的锌指核酸酶识别半位点:4. In order to verify the above two reporter vectors, specifically targeting the zinc finger nuclease recognition site on the bovine β casein gene, design the following zinc finger nuclease recognition half-sites on the casein gene:
具体设计以下三个锌指核酸酶识别位点CNS1,CNS2,CNS3(分别如SEQ.ID.NO.4~9所示)。每个识别位点包括了左右两个半识别位点,下划线部分为左右两个半结合位点序列。Specifically design the following three zinc finger nuclease recognition sites CNS1, CNS2, and CNS3 (respectively shown in SEQ.ID.NO.4-9). Each recognition site includes left and right half-recognition sites, and the underlined part is the sequence of the left and right two half-binding sites.
CNS1:1882TAGAAGCAACTATAAAGATTTGTAAC 1907CNS1: 1882TAGAAGCAACTATAAA GATTTGTAA C 1907
1882ATCTTCGTTGATATTTCTAAACATTG 19071882A TCTTCGTTG ATATTTTCTAAACATTG 1907
CNS2:3706CATCCTTGCCTGCCTGGTGGCTCTG 3730CNS2 : 3706CATCCTTGCCTGCCTGGTGGCTCTG 3730
3706GTAGGAACGGACGGACCACCGAGAC 37303706G TAGGAACGG ACGGACCACCGAGAC 3730
CNS3:3723TGGCTCTGGCCCTTGCAAGAGAGGTA3748CNS3: 3723TGGCTCTGGCCCTTGC AAGAGAGGT A3748
3723ACCGAGACCGGGAACGTTCTCTCCAT37483723A CCGAGACCG GGAACGTTCTTCTCAT3748
合成CNS1、CNS2、CNS3三个位点上6个半位点引物,通过退火获得6个半位点插入序列:CNS1Y,CNS1Z,CNS2Y,CNS2Z,CNS3Y,CNS3Z。Six half-site primers on the three sites of CNS1, CNS2, and CNS3 were synthesized, and six half-site insertion sequences were obtained by annealing: CNS1Y, CNS1Z, CNS2Y, CNS2Z, CNS3Y, and CNS3Z.
其中,Y代表锌指核酸酶右边的半识别位点,Z代表锌指核酸酶左边的半识别位点。Wherein, Y represents the half-recognition site on the right side of the zinc finger nuclease, and Z represents the half-recognition site on the left side of the zinc finger nuclease.
将设计得到的酪蛋白基因上的锌指核酸酶识别半位点分别通过Asc I和Nhe I插入pReport-N1-T-L-A报告载体中得到报告载体pReport-N1-T-L-A-CN,其中CN代表CNS1Y、CNS1CNS2Y、CNS2Z、CNS3Y或CNS3Z;Insert the zinc finger nuclease recognition half-site on the casein gene through Asc I and Nhe I into the pReport-N1-T-L-A reporter vector to obtain the reporter vector pReport-N1-T-L-A-CN, where CN represents CNS1Y, CNS1CNS2Y , CNS2Z, CNS3Y or CNS3Z;
Asc I和Nhe I双切pReport-N1-T-L-A报告载体如图7所示:其中M为trans15k,1为质粒,2为双酶切条带,大小为16360bp。Asc I and Nhe I double-cut pReport-N1-T-L-A reporter vector is shown in Figure 7: where M is trans15k, 1 is the plasmid, and 2 is the double restriction band with a size of 16360bp.
PCR鉴定报告载体pReport-N1-T-L-A-CN如图8所示:其中M为trans5k,1-22为挑取单克隆PCR鉴定条带,条带大小为750bp,其1,2,4,5,6,7,8,9,12,13,14,15,16,19,20为阳性克隆。The PCR identification report vector pReport-N1-T-L-A-CN is shown in Figure 8: where M is trans5k, 1-22 is the picked monoclonal PCR identification band, the band size is 750bp, its 1, 2, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15, 16, 19, 20 are positive clones.
同时将设计得到的酪蛋白基因上的锌指核酸酶识别半位点通过两个Bsu36I酶切位点插入pReport-N2-T-E-A报告载体中得到pReport-N2-T-E-A-CN,其中CN代表CNS1Y、CNS1CNS2Y、CNS2Z、CNS3Y或CNS3Z;At the same time, insert the zinc finger nuclease recognition half site on the casein gene through two Bsu36I restriction sites into the pReport-N2-T-E-A reporter vector to obtain pReport-N2-T-E-A-CN, where CN represents CNS1Y, CNS1CNS2Y , CNS2Z, CNS3Y or CNS3Z;
Bsu36I酶切pReport-N2-T-E-A报告载体如图9所示:其中M为trans15k;1为pReport-N2-EGFP Bsu361酶切图,其大小为14142bp;2为质粒pReport-N2-EGFP。The pReport-N2-T-E-A reporter vector digested with Bsu36I is shown in Figure 9: M is trans15k; 1 is the pReport-N2-EGFP Bsu361 restriction map, and its size is 14142bp; 2 is the plasmid pReport-N2-EGFP.
PCR鉴定pReport-N2-T-E-A-CN如图10所示:其中M为trans2Kplus;1,2为PCR鉴定条带,目的条带的大小为750bp。半位点中心位于转录起点-62,为最佳的结合位点。The PCR identification of pReport-N2-T-E-A-CN is shown in Figure 10: where M is trans2Kplus; 1, 2 are PCR identification bands, and the size of the target band is 750bp. The center of the half-site is located at the transcription start-62, which is the best binding site.
5、为了更好的实现锌指蛋白的筛选,将能够相互作用的Gal11p、Gal4分别设置在随机锌指库质粒和激活载体当中。Gal11p可以与Gal4两者相互作用,能够调控启动子转录与否,已被广泛应用于蛋白质与蛋白质或做研究中,如细菌双杂交系统和酵母双杂交系统。5. In order to better realize the screening of zinc finger proteins, the interacting Gal11p and Gal4 were respectively set in the random zinc finger library plasmid and the activation vector. Gal11p can interact with Gal4 and can regulate the transcription of promoters. It has been widely used in protein-to-protein research, such as bacterial two-hybrid systems and yeast two-hybrid systems.
如图11-1、11-2所示,当将设有的随机锌指库质粒转染到含有报告载体与激活载体都转染到宿主细菌中,如果位于报告载体的待筛选锌指蛋白结合位点能与随机锌指质粒中的某个锌指蛋白相互作用,则激活载体上GAL4与随机锌指库质粒上的与该锌指蛋白序列结合的GAL11P元件靠近并结合,GAL4与GAL11P结合后促使RNA聚合酶α结合在报告载体的启动子区从而激活报告基因LacZ或EGFP的表达(图11-1所示);如果待筛选的识别位点与锌指蛋白无相互作用则不能激活报告基因表达(图11-2所示)。As shown in Figures 11-1 and 11-2, when the set random zinc finger library plasmid is transfected into the host bacteria containing the reporter vector and the activation vector, if the zinc finger protein to be screened located in the reporter vector binds The site can interact with a certain zinc finger protein in the random zinc finger plasmid, then activate GAL4 on the vector and the GAL11P element that binds to the zinc finger protein sequence on the random zinc finger library plasmid to approach and combine, after GAL4 binds to GAL11P Promote the binding of RNA polymerase α to the promoter region of the reporter vector to activate the expression of the reporter gene LacZ or EGFP (as shown in Figure 11-1); if the recognition site to be screened has no interaction with the zinc finger protein, the reporter gene cannot be activated Expression (shown in Figure 11-2).
6、锌指蛋白的筛选及条件优化6. Screening and condition optimization of zinc finger proteins
1)将pAD-R-G载体转入DH5a中制备感受态细胞(参照分子克隆第二版超级感受态的制备方法),然后其中一部分转入pReport-N1-T-L-A-CN报告载体得到包含两种质粒的菌株DH5a-L,另一部分转入pReport-N2-T-E-A-CN报告载体得到包含两种质粒的菌株DH5a-E。1) Transfer the pAD-R-G vector into DH5a to prepare competent cells (refer to the method for preparing supercompetent cells in the second edition of molecular cloning), and then transfer a part of them into the pReport-N1-T-L-A-CN reporter vector to obtain cells containing two plasmids The other part of strain DH5a-L was transformed into pReport-N2-T-E-A-CN reporter vector to obtain strain DH5a-E containing two plasmids.
2)分别用包含两种质粒的菌株DH5a-L与菌株DH5a-E制备电转化细胞:接菌1%的新鲜菌种于SOB液体培养液,37℃培养8-10h至OD为0.8-1.0之间,接1ml菌液于100ml灭菌SOC培养液中于25℃-37℃培养,待OD为0.6时,收集100ml菌体,4℃,3000g离心5min,去上清,10%甘油洗菌体,4℃,5000g离心5min,重复两次,用400ul10%甘油悬浮菌体,以上步骤都在冰上操作。2) Use the strain DH5a-L and the strain DH5a-E containing the two plasmids to prepare electrotransformed cells: inoculate 1% of fresh strains in SOB liquid culture medium, and culture at 37°C for 8-10 hours until the OD is between 0.8-1.0 Occasionally, inoculate 1ml of bacterial liquid in 100ml of sterilized SOC culture medium and cultivate at 25°C-37°C. When the OD is 0.6, collect 100ml of bacterial cells, centrifuge at 3000g for 5min at 4°C, remove the supernatant, and wash the bacterial cells with 10% glycerol , 4°C, centrifuge at 5000g for 5min, repeat twice, suspend the bacteria with 400ul10% glycerol, and all the above steps are performed on ice.
3)电转化条件:将锌指蛋白库质粒浓度10ug到20ug每1ul为一梯度加入制备好的电转化感受态细胞中,1500-2500v电击5ms,冰上放置6min-8min,加入SOC培养液,37℃,120rpm摇菌1h,将摇菌所得的菌体涂于多种抗生素的固体培养基上筛选。调整各种抗生素的浓度,调整好培养液、培养基中葡萄糖的用量。电击杯规格:Gap(mm)2.0,Minimum Volume 40μl,Maximum Volume 400μl。电转化随机锌指库,将锌指库质粒加入制备的电转化细胞中,冰上操作。电击1800v-2500v,5ms。3) Electroporation conditions: Add the zinc finger protein library plasmid concentration of 10ug to 20ug per 1ul as a gradient into the prepared electroporation competent cells, 1500-2500v electric shock for 5ms, place on ice for 6min-8min, add SOC culture medium, Shake the bacteria at 37°C and 120rpm for 1 hour, and apply the bacteria obtained from the shaking to the solid medium of various antibiotics for screening. Adjust the concentration of various antibiotics, adjust the amount of glucose in the culture medium and culture medium. Electric shock cup specifications: Gap (mm) 2.0, Minimum Volume 40μl, Maximum Volume 400μl. Electrotransform the random zinc finger library, add the zinc finger library plasmid into the prepared electrotransformed cells, and operate on ice. Electric shock 1800v-2500v, 5ms.
电击后冰上放置6min,然后加入SOC液体培养液,37℃,120rpm培养1h后涂含多种抗生素的固体培养基上,37℃倒置培养。挑取单克隆鉴定。Place on ice for 6 minutes after electric shock, then add SOC liquid culture medium, culture at 37°C, 120rpm for 1h, then coat on solid medium containing various antibiotics, and culture at 37°C upside down. Pick a single clone for identification.
并且LacZ报告系统中要加入X-gal用来显示LacZ的活性。And X-gal should be added to the LacZ reporter system to display the activity of LacZ.
4)锌指蛋白的筛选及条件优化结果:4) Results of screening and condition optimization of zinc finger proteins:
制备电转化感受态细胞最佳的摇菌温度为26.7℃,确定电转化时最佳的电击条件为2000v,5ms,细胞的损伤最小。The optimal shaking temperature for preparing electrotransformation competent cells is 26.7°C, and the optimal electric shock condition for electrotransformation is 2000v, 5ms, and the cell damage is minimal.
确定最终的抗生素浓度kan为30ug/m;Cm为34ug/ml;Amp为50ug/ml;Sm的浓度<80ug/ml,0.2%gluclose,IPTG为50uM。Determine the final antibiotic concentration kan is 30ug/m; Cm is 34ug/ml; Amp is 50ug/ml; Sm concentration<80ug/ml, 0.2%gluclose, IPTG is 50uM.
5)在报告载体报告表达后,PCR鉴定筛选得到的锌指蛋白,结果如图12所示:其中M为50bpmarker(从下而上为50bp,100bp,150bp,200bp,250bp,300bp,400bp,500bp)1-7为筛选得到菌株质粒PCR结果,片段大小为273bp。5) After reporting the expression of the reporter vector, the zinc finger protein obtained by PCR identification and screening is shown in Figure 12: wherein M is a 50bp marker (from bottom to top is 50bp, 100bp, 150bp, 200bp, 250bp, 300bp, 400bp, 500bp ) 1-7 is the PCR result of strain plasmid obtained by screening, and the fragment size is 273bp.
6)锌指蛋白EGFP/LacZ活性的测定6) Determination of zinc finger protein EGFP/LacZ activity
筛选得到的锌指蛋白抗链霉素浓度高达80ug/ml,得到的锌指蛋白测定EGFP/LacZ活性。提取所得单克隆的质粒,经过两次重接与两次重转得到纯度较高的随机锌指蛋白质粒,将LacZ系统筛选到的锌指蛋白质粒转EGFP系统,测定其EGFP强度;将EGFP系统筛选到的锌指蛋白质粒转LacZ系统测定其LacZ活性。两种系统的交互使用加强了筛选得到的锌指蛋白的可信度。PCR并测序鉴定所筛选到的锌指蛋白。The anti-streptomycin concentration of the zinc finger protein obtained by screening was as high as 80ug/ml, and the EGFP/LacZ activity of the obtained zinc finger protein was determined. The resulting monoclonal plasmid was extracted, and random zinc finger protein particles with high purity were obtained through two rejoining and two retransformation, and the zinc finger protein particles screened by the LacZ system were transferred to the EGFP system, and the EGFP intensity was determined; the EGFP system The screened zinc finger proteins were transfected into LacZ system to measure their LacZ activity. The interactive use of the two systems strengthens the reliability of the zinc finger proteins screened. The zinc finger proteins screened were identified by PCR and sequencing.
其中Lac活性测定的方法:从玻璃皿中挑取筛选得到的单克隆,接于含多种抗生素(kan为30ug/m;Cm为34ug/ml;Amp为50ug/ml;Sm的浓度为40ug/ml)的soc培养液中,37℃,200rpm过夜摇菌。将过夜摇得的菌液100ul接于新鲜的soc培养液中37℃,200rpm摇至OD至0.8左右。收集菌体(12000rpm离心1min),用Z Buffer洗剂菌体2次以除去残留的培养液,稀释菌体使得其od600介于0.8左右,将所得的菌液200ul加入96孔板中用od仪准确测定每个菌液OD600值,以pReprorT-N1-LacZ质粒菌株为对照组,以Z Buffer溶液为误差对照组。取100ul菌液加入11ul的裂解液A,室温下裂解15min。将Z Buffer含巯基乙醇135ul,30ml 4mg/ml的ONPG混匀加入9孔板中然后将所得的裂解液取15ul加入,混匀。应用动态法测定OD420值,测定50分钟内OD420值的变化,每隔50秒测定一次,以Z Buffer含巯基乙醇及ONPG混合物做对照组。以时间轴对得到的OD420值作图,所得的趋势线斜率为ONPG的裂解速率(V),利用公式LacZ活性=V*1000/OD600得到最终的LacZ活性。测得lacz活性如表1所示,相对于对照组,实验组即筛选得到的锌指蛋白明显提高了lacz的活性。Wherein the method of Lac activity assay: pick the monoclonal that screens and obtain from the glass dish, inoculate with various antibiotics (kan is 30ug/m; Cm is 34ug/ml; Amp is 50ug/ml; the concentration of Sm is 40ug/ml; ml) of soc culture medium, shake overnight at 37°C and 200 rpm. Inoculate 100 ul of the overnight shaken bacterial solution into fresh soc culture solution at 37°C and shake at 200 rpm until the OD reaches about 0.8. Collect the bacteria (centrifuge at 12000rpm for 1min), wash the bacteria twice with Z Buffer to remove the residual culture solution, dilute the bacteria so that their od600 is around 0.8, add 200ul of the obtained bacteria solution into a 96-well plate and use an od instrument Accurately measure the OD600 value of each bacterial solution, use the pReprorT-N1-LacZ plasmid strain as the control group, and use the Z Buffer solution as the error control group. Take 100 ul of bacterial liquid and add 11 ul of Lysis Solution A, and lyse for 15 min at room temperature. Mix 135ul of Z Buffer containing mercaptoethanol and 30ml of 4mg/ml ONPG into a 9-well plate, then add 15ul of the obtained lysate, and mix well. The dynamic method was used to measure the OD420 value, and the change of the OD420 value within 50 minutes was measured every 50 seconds. The Z Buffer containing mercaptoethanol and ONPG mixture was used as the control group. The obtained OD420 value was plotted on the time axis, and the slope of the obtained trend line was the cleavage rate (V) of ONPG, and the final LacZ activity was obtained by using the formula LacZ activity=V*1000/OD600. The measured lacz activity is shown in Table 1. Compared with the control group, the zinc finger protein obtained by screening in the experimental group significantly increased the activity of lacz.
表1筛选的锌指蛋白的lacz的活性Table 1 The activity of lacz of the zinc finger protein screened
而EGFP强度测定的方法:从玻璃皿中挑取筛选得到的单克隆,接于含多种抗生素(kan为30ug/m;Cm为34ug/ml;Amp为50ug/ml;Sm的浓度为40ug/ml)的soc培养液中,37℃,200rpm过夜摇菌。将过夜摇得的菌液100ul接于新鲜的soc培养液中37℃,200rpm摇至OD至0.8左右。收集菌体(12000rpm离心1min),用磷酸钠洗剂菌体2次以除去残留的培养液,稀释菌体使得其od600介于0.5左右,将所得的菌液200ul加入96孔酶标板中用酶标仪准确测定每个菌液OD600值,以报告载体菌株pReprorT-EGFP为对照组,用磷酸钠溶液为误差对照组。然后测定其荧光强度,荧光强度的测定条件,应用酶标仪设定荧光激发光波长为491nm,荧光的发射波长为511nm,EGFP强度的测定在低于22℃下进行。测定的荧光强度/OD600为最终菌株的荧光强度。测定的EGFP活性如表2所示,相对于对照组,实验组即筛选得到的锌指蛋白明显提高了EGFP的表达。And the method of EGFP intensity measurement: pick the monoclonal that screens and obtain from the glass dish, inoculate and contain various antibiotics (kan is 30ug/m; Cm is 34ug/ml; Amp is 50ug/ml; Sm concentration is 40ug/ml; ml) of soc culture medium, shake overnight at 37°C and 200 rpm. Inoculate 100 ul of the overnight shaken bacterial solution into fresh soc culture solution at 37°C and shake at 200 rpm until the OD reaches about 0.8. Collect the bacteria (centrifuge at 12000rpm for 1min), wash the bacteria twice with sodium phosphate to remove the residual culture solution, dilute the bacteria so that their od600 is about 0.5, and add 200ul of the obtained bacteria solution into a 96-well microplate plate for use The microplate reader accurately measured the OD600 value of each bacterial solution, the reporter carrier strain pReprorT-EGFP was used as the control group, and the sodium phosphate solution was used as the error control group. Then measure its fluorescence intensity, the determination condition of fluorescence intensity, adopt microplate reader to set the wavelength of fluorescence excitation light as 491nm, the emission wavelength of fluorescence as 511nm, the determination of EGFP intensity is carried out under 22 ℃. The measured fluorescence intensity/OD600 is the fluorescence intensity of the final strain. The measured EGFP activity is shown in Table 2. Compared with the control group, the zinc finger protein obtained by screening in the experimental group significantly increased the expression of EGFP.
表2筛选的锌指蛋白的EGFP的活性Table 2 The activity of EGFP of the zinc finger protein screened
应用上述构建的筛选系统,对于牛β酪蛋白基因上的锌指核酸酶结合位点进行筛选,得到了高效的锌指蛋白。通过抗生素筛选、lacz活性测定及EGFP的高表达验证了筛选得到的锌指蛋白的活性,并且筛选得到的锌指蛋白已经在牛成纤维细胞上进行了验证,其效果良好。The screening system constructed above was used to screen the zinc finger nuclease binding site on the bovine β-casein gene, and a high-efficiency zinc finger protein was obtained. The activity of the screened zinc finger protein was verified by antibiotic screening, lacz activity measurement and high expression of EGFP, and the screened zinc finger protein has been verified on bovine fibroblasts, and the effect is good.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101228853A CN102660642A (en) | 2012-04-24 | 2012-04-24 | Screening system for screening zinc finger protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101228853A CN102660642A (en) | 2012-04-24 | 2012-04-24 | Screening system for screening zinc finger protein |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102660642A true CN102660642A (en) | 2012-09-12 |
Family
ID=46770217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101228853A Pending CN102660642A (en) | 2012-04-24 | 2012-04-24 | Screening system for screening zinc finger protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102660642A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103160534A (en) * | 2013-03-26 | 2013-06-19 | 西北农林科技大学 | Universal type bovine beta-casein site gene targeting vector and preparation method thereof |
CN103215295A (en) * | 2013-04-11 | 2013-07-24 | 西北农林科技大学 | Targeting vector for integrating Lys gene at fixed point of bate-casein locus and cells constructed thereby |
CN103695375A (en) * | 2013-12-30 | 2014-04-02 | 佛山安普泽生物医药有限公司 | Method for quickly constructing high-expression and stable cell strains |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285846A (en) * | 1997-11-10 | 2001-02-28 | 综合医院公司 | Detection systems for registering protein interactions and functional relationships |
WO2001088197A2 (en) * | 2000-05-16 | 2001-11-22 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
CN1350062A (en) * | 2000-10-17 | 2002-05-22 | 罗姆和哈斯公司 | Method of identifying production using gene expression |
CN1438323A (en) * | 2003-01-08 | 2003-08-27 | 中国人民解放军军事医学科学院生物工程研究所 | Genetic-sorting model of zinc finger-protein-DNA interaction and use thereof |
WO2011011767A1 (en) * | 2009-07-24 | 2011-01-27 | Sigma-Aldrich Co. | Method for genome editing |
WO2011091324A2 (en) * | 2010-01-22 | 2011-07-28 | The Scripps Research Institute | Methods of generating zinc finger nucleases having altered activity |
-
2012
- 2012-04-24 CN CN2012101228853A patent/CN102660642A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285846A (en) * | 1997-11-10 | 2001-02-28 | 综合医院公司 | Detection systems for registering protein interactions and functional relationships |
WO2001088197A2 (en) * | 2000-05-16 | 2001-11-22 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
CN1350062A (en) * | 2000-10-17 | 2002-05-22 | 罗姆和哈斯公司 | Method of identifying production using gene expression |
CN1438323A (en) * | 2003-01-08 | 2003-08-27 | 中国人民解放军军事医学科学院生物工程研究所 | Genetic-sorting model of zinc finger-protein-DNA interaction and use thereof |
WO2011011767A1 (en) * | 2009-07-24 | 2011-01-27 | Sigma-Aldrich Co. | Method for genome editing |
WO2011091324A2 (en) * | 2010-01-22 | 2011-07-28 | The Scripps Research Institute | Methods of generating zinc finger nucleases having altered activity |
Non-Patent Citations (2)
Title |
---|
JESSICA A. HURT等: "Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection", 《PNAS》 * |
李战伟 等: "人工锌指蛋白随机库的构建及其在锌指核酸酶筛选中的应用", 《西北农业学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103160534A (en) * | 2013-03-26 | 2013-06-19 | 西北农林科技大学 | Universal type bovine beta-casein site gene targeting vector and preparation method thereof |
CN103215295A (en) * | 2013-04-11 | 2013-07-24 | 西北农林科技大学 | Targeting vector for integrating Lys gene at fixed point of bate-casein locus and cells constructed thereby |
CN103215295B (en) * | 2013-04-11 | 2015-04-22 | 西北农林科技大学 | Targeting vector for integrating Lys gene at fixed point of bate-casein locus and cells constructed thereby |
CN103695375A (en) * | 2013-12-30 | 2014-04-02 | 佛山安普泽生物医药有限公司 | Method for quickly constructing high-expression and stable cell strains |
CN103695375B (en) * | 2013-12-30 | 2015-08-26 | 佛山安普泽生物医药有限公司 | A kind of method of rapid build high expression level stability cell strain |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103224947B (en) | Gene targeting system | |
CN108690845B (en) | Genome editing systems and methods | |
CN105695485B (en) | A Cas9-encoding gene for filamentous fungal Crispr-Cas system and its application | |
JP2023002712A (en) | S. pyogenes CAS9 mutant gene and polypeptide encoded thereby | |
US10612043B2 (en) | Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events | |
CN109136248B (en) | Multi-target editing vector and construction method and application thereof | |
CN108559732A (en) | The method for establishing KI-T2A-luciferase cell lines based on CRISPR/Cas9 targeted genomic modification technologies | |
CN110527697B (en) | RNA site-directed editing technology based on CRISPR-Cas13a | |
CN111373041A (en) | CRISPR/CAS systems and methods for genome editing and regulation of transcription | |
WO2018099475A1 (en) | Site-directed editing method for plant genome based on cpf1 | |
CN113789317A (en) | Gene editing using RNA-guided engineered nucleases derived from the Campylobacter jejuni CRISPR/CAS system | |
CA3228222A1 (en) | Class ii, type v crispr systems | |
CN110257420A (en) | Plant gene silencing carrier and its construction method and application based on CasRx | |
CN107245493B (en) | Vector for expressing aptamer ribozyme modified sgRNA regulated and controlled by theophylline and application | |
US20230167435A1 (en) | Autoinducer-2 (ai-2) molecular response-based starting element and escherichia coli (e. coli) dynamic regulation system and method constructed thereby | |
CN102660642A (en) | Screening system for screening zinc finger protein | |
CN107475298A (en) | CdtB gene overexpressions slow virus carrier and its construction method and the slow virus comprising cdtB genes and its application | |
CN106282119A (en) | A kind of transformation of site-directed integration Chinese hamster ovary cell strain and application thereof | |
CN104630229B (en) | A kind of DNA fragmentation and application with promoter function | |
US20240200047A1 (en) | Enzymes with ruvc domains | |
CN103146818B (en) | Recombinase Cre modification method, and application of modified recombinase Cre in plants | |
JP2025507834A (en) | Cas12a nickase | |
CN103525854A (en) | Construction method for high-gene-knockout-efficiency Aspergillus chevalieri var. intermedius mutant engineering bacterial strain | |
CN102181381A (en) | Method for constructing bacterium surface antigen Ag43 expression system | |
CN111378674A (en) | Myceliophthora isopterans glucoamylase MhglaA, coding gene thereof and application thereof in glucose production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120912 |